Therapeutic prospects for epigenetic modulation

Bibliography

• Waddington CH. The strategy of the genes; a discussion of some aspects of theoretical biology. Allen & Unwin, London; 1957
   Google Scholar
• Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003;33(Suppl):245-54
   PubMed Web of Science ®Google Scholar
• Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006;31(2):89-97
   PubMedGoogle Scholar
• Kouzarides T. Chromatin modifications and their function. Cell 2007;128(4):693-705
   PubMedGoogle Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281-97
   PubMed Web of Science ®Google Scholar
• Baek D, Villen J, Shin C, The impact of microRNAs on protein output. Nature 2008;455(7209):64-71
   PubMed Web of Science ®Google Scholar
• Sleutels F, Zwart R, Barlow DP. The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 2002;415(6873):810-13
   PubMedGoogle Scholar
• Feng J, Sun G, Yan J, Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS One 2009;4(7):e6121
   Google Scholar
• Zippo A, Serafini R, Rocchigiani M, Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 2009;138(6):1122
   PubMedGoogle Scholar
• Santos F, Dean W. Epigenetic reprogramming during early development in mammals. Reproduction 2004;127(6):643-51
   PubMedGoogle Scholar
• Lee J-H, Hart SRL, Skalnik DG. Histone deacetylase activity is required for embryonic stem cell differentiation. Genesis 2004;38(1):32-8
   PubMedGoogle Scholar
• Pan G, Tian S, Nie J, Whole-genome analysis of histone H3 Lysine 4 and Lysine 27 methylation in human embryonic stem cells. Cell Stem Cell 2007;1(3):299-312
   PubMedGoogle Scholar
• Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359(1):61-73
   PubMedGoogle Scholar
• Ravelli G-P, Stein ZA, Susser MW. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 1976;295(7):349-53
   PubMed Web of Science ®Google Scholar
• Liguori A, Puglianiello A, Germani D, Epigenetic changes predisposing to type 2 diabetes in intrauterine growth retardation. Front Endocrinol 2010 [Epub ahead of print]; doi: 10.3389/fendo.2010.00005.
   PubMedGoogle Scholar
• Hollingsworth JW, Maruoka S, Boon K, In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008;118(10):3462-9
   PubMedGoogle Scholar
• Sugden C. One-carbon metabolism in psychiatric illness. Nutr Res Rev 2006;19:117-36
   PubMedGoogle Scholar
• Hunter RG, McCarthy KJ, Milne TA, Regulation of hippocampal H3 histone methylation by acute and chronic stress. Proc Natl Acad Sci USA 2009;106(49):20912-17
   PubMedGoogle Scholar
• Fraga MF, Ballestar E, Paz MF, Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005;102(30):10413-14
   PubMedGoogle Scholar
• Javierre BM, Fernandez AF, Richter J, Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 2010;20(2):170-9
   PubMed Web of Science ®Google Scholar
• Chung H, Sidhu KS. Epigenetic modifications of embryonic stem cells: current trends and relevance in developing regenerative medicine. Stem Cells Cloning Adv Appl 2008;1:11-21
   PubMedGoogle Scholar
• Kim K, Doi A, Wen B, Epigenetic memory in induced pluripotent stem cells. Nature 2010;467(7313):285-90
   PubMedGoogle Scholar
• Smiraglia J. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 2001;10(13):1413-19
   PubMedGoogle Scholar
• Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005;2:S4-11
   PubMedGoogle Scholar
• Paris M, Porcelloni M, Binaschi M, Fattori D. Histone deacetylase inhibitors: from bench to clinic. J Med Chem 2008;51(6):1505-29
   PubMedGoogle Scholar
• Olsen EA, Kim YH, Kuzel TM, Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. J Clin Oncol 2007;25(21):3109
   PubMed Web of Science ®Google Scholar
• Bots M, Johnstone RW. Rational combinations using HDAC inhibitors. Clin Cancer Res 2009;15:3970
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Ramos J, Luo W, A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas. Leukemia 2008;22(5):1026-34
   PubMed Web of Science ®Google Scholar
• Frye SV, Heightman TD, Jin J. Targeting methyl lysine. Annu Rep Med Chem 2010;45:329
   Google Scholar
• Kleer CG, Cao Q, Varambally S, EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 2003;100(20):11606-11
   PubMedGoogle Scholar
• Varambally S, Dhanasekaran SM, Zhou M, The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002;419(6907):624-9
   PubMedGoogle Scholar
• Kondo Y, Shen L, Ahmed S, Downregulation of histone H3 Lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One 2008;3(4):e2037
   Google Scholar
• Huang J, Berger SL. The emerging field of dynamic lysine methylation of non-histone proteins. Curr Opin Genet Dev 2008;18(2):152-8
   PubMedGoogle Scholar
• Okada Y, Feng Q, Lin Y, hDOT1L links histone methylation to leukemogenesis. Cell 2005;121(2):167-78
   PubMedGoogle Scholar
• Kahl P, Gullotti L, Heukamp LC, Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 2006;66(23):11341-7
   PubMedGoogle Scholar
• Metzger E, Wissmann M, Yin N, LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005;437(7057):436-9
   PubMedGoogle Scholar
• Yamane K, Tateishi K, Klose RJ, PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol Cell 2007;25(6):801-12
   PubMedGoogle Scholar
• Cloos PAC, Christensen J, Agger K, Helin K. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev 2008;22(9):1115-40
   PubMedGoogle Scholar
• Yang Z, He N, Zhou Q. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol Cell Biol 2008;28(3):967-76
   PubMedGoogle Scholar
• Crawford NP, Alsarraj J, Lukes L, Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci USA 2008;105(17):6380-5
   PubMedGoogle Scholar
• French CA, Kuto JL, Faquin WC, Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004;22(20):4135-9
   PubMedGoogle Scholar
• Haruki N, Kawaguchi KS, Eichenberger S, Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro. J Med Genet 2005;42(7):558-64
   PubMedGoogle Scholar
• Filippakopoulos P, Qi J, Picaud S, Selective inhibition of BET bromodomains. Nature 2010;468(7327):1067-73
   Google Scholar
• Ho S-K. Environmental epigenetics of asthma: an update. J Allergy Clin Immunol 2010;126(3):453-65
   PubMedGoogle Scholar
• Wei G, Wei L, Zhu J, Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009;30(1):155-67
   PubMedGoogle Scholar
• Karouzakis E, Gay RE, Gay S, Neidhart M. Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol 2009;5(5):266-72
   PubMedGoogle Scholar
• Schildberg FA, Hagmann CA, Bohnert V, Tolba RH. Improved transplantation outcome by epigenetic changes. Transplant Immunol 2010;23(3):104-10
   PubMedGoogle Scholar
• Adcock IM. HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 2007;150(7):829-31
   PubMed Web of Science ®Google Scholar
• Villagra A, Cheng F, Wang H-W, The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance. Nat Immunol 2009;10(1):92
   PubMed Web of Science ®Google Scholar
• Camelo S, Iglesias AH, Hwang D, Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. J Neuroimmunol 2005;164(1-2):10-21
   PubMedGoogle Scholar
• Huang B, Yang XD, Zhou MM, Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol Cell Biol 2009;29(5):1375-87
   PubMedGoogle Scholar
• Nicodeme E, Jeffrey KL, Schaefer U, Suppression of inflammation by a synthetic histone mimic. Nature 2010;468(7327):1119-23
   PubMedGoogle Scholar
• De Santa F, Narang V, Yap ZH, Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J 2009;28:3341-52
   PubMed Web of Science ®Google Scholar
• Tsankova N, Renthal W, Kumar A, Nestler EJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007;8(5):355-67
   PubMedGoogle Scholar
• Szyf M. Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 2009;49:243-63
   PubMed Web of Science ®Google Scholar
• McGowan PO, Sasaki A, D'Alessio AC, Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009;12(3):342-8
   PubMed Web of Science ®Google Scholar
• Poulter MO, Du L, Weaver IC, GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 2008;64(8):645-52
   PubMedGoogle Scholar
• Uchida H, Ma L, Ueda H. Epigenetic gene silencing underlies C-fiber dysfunctions in neuropathic pain. J Neurosci 2010;30:4806-14
   PubMed Web of Science ®Google Scholar
• Amir RE, Van den Veyver IB, Wan M, Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23(2):185-8
   PubMedGoogle Scholar
• Chouliaras L, Rutten BP, Kenis G, Epigenetic regulation in the pathophysiology of Alzheimer's disease. Prog Neurobiol 2010;90(4):498-510
   PubMedGoogle Scholar
• Hahnen E, Hauke J, Trankle C, Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 2008;17(2):169-84
   PubMedGoogle Scholar
• Pacholec M, Bleasdale JE, Chrunyk B, SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 2010;285(11):8340-51
   PubMedGoogle Scholar
• Ding H, Dolan PJ, Johnson GV. Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 2008;106:2119-30
   PubMed Web of Science ®Google Scholar
• Butler KV, Kalin J, Brochier C, Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J Am Chem Soc 2010;132(31):10842-6
   PubMedGoogle Scholar
• Guan JS, Haggarty SJ, Giacometti E, HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009;459(7243):55-60
   PubMedGoogle Scholar
• MacFarlane AJ, Strom A, Scott FW. Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes. Mamm Genome 2009;20(9-10):624-32
   PubMedGoogle Scholar
• Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009;33(1):3-11
   PubMedGoogle Scholar
• Brasacchio D, Okabe J, Tikellis C, Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009;58(5):1229-36
   PubMedGoogle Scholar
• Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 2009;58(12):2718-25
   PubMedGoogle Scholar
• Tateishi K, Okada Y, Kallin EM, Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 2009;458(7239):757-61
   PubMedGoogle Scholar
• Liang Y, Vogel JL, Narayanan A, Inhibition of the histone demethylase LSD1 blocks [alpha]-herpesvirus lytic replication and reactivation from latency. Nat Med 2009;15(11):1312-17
   PubMedGoogle Scholar
• Zhou M, Huang K, Jung KJ, Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. J Virol 2009;83(2):1036-44
   PubMedGoogle Scholar
• Lin A, Wang S, Nguyen T, The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. J Virol 2008;82(24):12009-19
   PubMedGoogle Scholar
• Gagnon D, Joubert S, Senechal H, Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J Virol 2009;83(9):4127-39
   PubMedGoogle Scholar
• Pagans S, Pedal A, North BJ, SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 2005;3(2):e41
   PubMedGoogle Scholar
• Mantelingu K, Reddy BA, Swaminathan V, Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol 2007;14(6):645-57
   PubMedGoogle Scholar
• Issa J-PJ, Kantarjian HM. Targeting DNA methylation. Clin Cancer Res 2009;15(12):3938-46
   PubMedGoogle Scholar
• Manzo F, Tambaro FP, Mai A, Altucci L. Histone acetyltransferase inhibitors and preclinical studies. Expert Opin Ther Pat 2009;19(6):761-74
   PubMedGoogle Scholar
• Bowers EM, Yan G, Mukherjee C, Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. Chem Biol 2010;17(5):471-82
   PubMedGoogle Scholar
• Tan J, Cang S, Ma Y, Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 2010;3:5
   PubMed Web of Science ®Google Scholar
• Hamada S, Suzuki T, Mino K, Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors. J Med Chem 2010;53(15):5629-38
   PubMedGoogle Scholar
• King ONF, Li XS, Sakurai M, Quantitative high-throughput screening identifies 8-hydroxyquinolines as cell-active histone demethylase inhibitors. PLoS One 2010;5(11):e15535
   Google Scholar
• Liu F, Chen X, Allali-Hassani A, Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J Med Chem 2009;52(24):7950-3
   PubMed Web of Science ®Google Scholar
• Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007;26(37):5541-52
   PubMedGoogle Scholar